The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,094.00
Bid: 12,094.00
Ask: 12,096.00
Change: -62.00 (-0.51%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,098.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks Lower But Sirius Minerals And Greggs Gain

Mon, 11th Nov 2019 08:43

(Alliance News) - London stocks started the week on the back foot amid some rising unease over the US-China trade situation following a week of mixed headlines, with the FTSE 250 lower despite Sirius Minerals, Greggs and Aston Martin all racking up share price gains.

The FTSE 100 was 39.32 points lower, or 0.5%, at 7,320.06 early Monday. The FTSE 250 was down 65.24 points, or 0.3%, at 20,292.39, and the AIM All-Share was down 0.1% at 890.78.

The Cboe UK 100 index was up down 0.6% at 12,406.34. The Cboe UK 250 was down 0.1% at 18,233.01 and the Cboe UK Small Companies was flat at 11,258.26.

In European equities, the CAC 40 index in Paris was down 0.1% and the DAX 30 in Frankfurt down 0.3% in early trade.

In Asia on Monday, the Japanese Nikkei 225 index closed down 0.3%. In China, the Shanghai Composite ended down 1.8%, while the Hang Seng index in Hong Kong finished 2.6% lower.

"Civil unrest in Hong Kong and mixed signals on the progress of US/China trade talks has dampened sentiment across financial markets. Most Asian equity markets have started the week lower as a result, with Hong Kong stocks leading the decline following violent clashes this morning," said Lloyds Banking.

Though there were broad-based losses in the FTSE 100, AstraZeneca was sat atop the index, up 0.9% after reporting positive results for an anaemia drug.

Astra said analyses of a Roxadustat drug trial for the treatment of patients with anaemia from chronic kidney disease showed positive efficacy and no increased risk of major adverse cardiovascular events.

The FTSE 250 was lower despite some solid share price gains from the likes of Sirius Minerals, Greggs and Aston Martin.

Sirius Minerals shares surged 14% after outlining a new two-stage development plan for its North Yorkshire polyhalite mine as it looks to secure funding for the first stage of the project.

In September, Sirius announced it struggled to secure the required funding for its current project plan due to "market conditions." Consequently, the firm intended to slow the development of its polyhalite mine.

Sirius remains focused on extracting first polyhalite from the mine in order to remove the "greatest perceived construction risk associated with deep shaft construction." This will allow Sirius to explore a wider and cheaper range of long-term financing options for the ramping-up of production.

The Scarborough-based firm expects the initial phase to require around USD600 million in investment in addition to its current cash reserves.

Baker Greggs was up 6.9% after upgrading its guidance again.

In the period to November 9, total sales were up 12% year-on-year and the bakery chain registered like-for-like growth of 8.3% in its company-managed shops. In the same period last year, total sales rose by 8.3% and by 4.0% on a like-for-like basis.

The FTSE 250 firm now expects its full-year pretax profit, excluding exceptional costs, to be higher than previous internal expectations.

Greggs explained: "Sales growth continues to be driven by increased customer visits and has been stronger than we had expected given the improving comparative sales pattern that we saw in the fourth quarter last year. Operational costs remain well controlled and, whilst the comparative sales become stronger still in the balance of the year."

The company previously hiked its 2019 pretax profit guidance in February, after reporting a sales surge helped by its vegan sausage rolls.

Aston Martin shares rose 5.0% after HSBC raised the stock to Buy from Hold.

In Monday's economic calendar, there are UK GDP, manufacturing production, industrial production and trade balance reports at 0930 GMT.

"Given the weak PMIs, growth seems to remain sluggish but there might have been a positive contribution from stockpiling ahead of the previous 31 October Brexit deadline," commented Danske Bank.

Consensus, according to FXStreet, is for UK GDP in the third quarter of grow 0.3% quarter-on-quarter, after a 0.2% contraction in the preceding three months. Any reading which indicates the UK economy shrank in the three months to September will put the country into a technical recession.

The data comes after Moody's Investors Service on Friday downgraded the outlook for Britain's debt, citing mounting policy challenges amid the Brexit debate.

The agency cut the outlook to negative from stable but kept the debt at the investment-grade Aa2. Ratings agency Fitch had similarly put Britain on "negative watch" in February.

Pointing to "paralysis that has characterised the Brexit-era policymaking process," Moody's said London has "struggled to cope with the magnitude of policy challenges that they currently face."

The pound was quoted at USD1.2799 early Monday, up from USD1.2784 late Friday.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
Today 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.